Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization
- PMID: 15845698
- DOI: 10.1213/01.ANE.0000150610.44631.9D
Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization
Abstract
Patients who receive allogeneic blood transfusions after orthopedic surgery have a longer duration of hospitalization, and this cannot be explained by a more frequent incidence of infections in transfused patients. To determine whether transfusion of allogeneic blood interferes with wound healing and therefore increases the duration of hospitalization, we performed an observational study in 444 consecutive patients scheduled for elective primary hip surgery. Transfusion, wound, and infection variables were collected at five time points during treatment. Of the 444 consecutive patients studied, 92 received blood transfusions during their perioperative course. Thirty-one percent of transfused patients developed wound-healing disturbances versus 18% of the nontransfused group (P < 0.05); allogeneic blood transfusion was the only significant predictor for development of minor wound-healing disturbances. Duration of hospitalization was prolonged in transfused patients (12.3 versus 9.8 days) and could be predicted by 4 significant variables: requirement for blood transfusion (adds 2.7 +/- 0.5 days), presence of wound-healing disturbances (adds 1.3 +/- 0.5 days), duration of surgery (adds 0.2 +/- 0.1 days/10 min), and patient's age (adds 0.9 +/- 0.2 days/10 yr). These data suggest that allogeneic blood transfusion is associated with an increased incidence of wound-healing disturbances and that prevention of allogeneic blood transfusion may be relevant in limiting the duration of admission after elective orthopedic surgery.
Comment in
-
Allogeneic blood transfusion and wound healing disturbance after orthopaedic surgery.Anesth Analg. 2005 Dec;101(6):1889-1890. doi: 10.1213/01.ANE.0000180280.63468.93. Anesth Analg. 2005. PMID: 16301290 No abstract available.
References
-
- Dodd RY. The risk of transfusion-transmitted infection. N Engl J Med 1992;327:419–21.
-
- Busch MP, Lee TH, Heitman J. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood 1992;80:2128–35.
-
- Duffy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus Med 1996;6:325–8.
-
- Blumberg N, Heal JM. Effects of transfusion on immune function: cancer recurrence and infection. Arch Pathol Lab Med 1994;118:371–9.
-
- Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995;35:760–8.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
